Outlook Therapeutics (OTLK) Depreciation & Amortization (CF) (2015 - 2026)
Outlook Therapeutics' Depreciation & Amortization (CF) was $13,791 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 53.1% from $29,412 a year earlier and down 54.7% from the prior quarter.
Outlook Therapeutics (OTLK) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Outlook Therapeutics' Depreciation & Amortization (CF) was $104,019 through Jun 30, 2026, down 10.4% year-over-year; for FY2025 (ended Sep 30, 2025), it was $117,052, up 2.8% from FY2024.
- Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -26.7% (FY2020 to FY2025).
- In earlier fiscal years, Depreciation & Amortization (CF) was $113,859 in FY2024 (+157.7%), $44,188 in FY2023 (-78.4%), $204,694 in FY2022 (-21.9%) and $262,140 in FY2021 (-52.7%).
- The fiscal Q3 2026 figure marks the lowest quarterly Depreciation & Amortization (CF) since fiscal Q4 2023.
- Compared with a year earlier, Depreciation & Amortization (CF) was higher in seven of the last eight quarters, with growth averaging 15.5%.
- The best year-over-year quarter for Depreciation & Amortization (CF) over five years was fiscal Q1 2024 (growth of 161.6%); the worst was fiscal Q1 2023 (a decline of 78.8%).
- Per Business Quant data, OTLK's Depreciation & Amortization (CF) in the three fiscal quarters before Q3 2026 was $30,417 (Q2 2026), $30,074 (Q1 2026) and $29,737 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Outlook Therapeutics | 77.94 Mn | 42.19 Mn | -8,265.00 | 13,791.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13,791.00 |
| Mar 31, 2026 | 30,417.00 |
| Dec 31, 2025 | 30,074.00 |
| Sep 30, 2025 | 29,737.00 |
| Jun 30, 2025 | 29,412.00 |
| Mar 31, 2025 | 29,102.00 |
| Dec 31, 2024 | 28,801.00 |
| Sep 30, 2024 | 28,797.00 |
| Jun 30, 2024 | 28,672.00 |
| Mar 31, 2024 | 28,195.00 |
| Dec 31, 2023 | 28,195.00 |
| Sep 30, 2023 | 11,217.00 |
| Jun 30, 2023 | 11,192.00 |
| Mar 31, 2023 | 11,001.00 |
| Dec 31, 2022 | 10,778.00 |
| Sep 30, 2022 | 51,470.00 |
| Jun 30, 2022 | 51,271.00 |
| Mar 31, 2022 | 51,085.00 |
| Dec 31, 2021 | 50,868.00 |
| Sep 30, 2021 | 50,674.00 |
Outlook Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();